X hits on this document

466 views

0 shares

0 downloads

0 comments

6 / 170

Endocrinologic and Metabolic Drugs Advisory Committee Hilton Hotel, Washington DC-Silver Spring Silver Spring, Maryland April 1, 2009

Meeting Roster

___________________________________________________________________ ENDOCRINOLOGY AND METABOLIC DRUGS ADVISORY COMMITTEE MEMBERS (Voting)

Kenneth D. Burman, M.D. (Chair) Chief, Endocrine Section Washington Hospital Center Washington, District of Columbia

Eric I. Felner, M.D. Emory University School of Medicine Department of Pediatrics Division of Endocrinology Atlanta, Georgia

Katherine M. Flegal, Ph.D. Senior Research Scientist Distinguished Consultant National Center for Health Statistics Centers for Disease Control and Prevention Hyattsville, Maryland

Jessica W. Henderson, Ph.D. Associate Professor Division of Health and Physical Education Western Oregon University Monmouth, Oregon

Michael A. Proschan, Ph.D. Mathematical Statistician Biostatistics Research Branch National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health (NIH) Bethesda, Maryland

ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE MEMBERS, INDUSTRY REPRESENTATIVE (Non-Voting)

Enrico P. Veltri, M.D. Group Vice President Global Clinical Development Cardiovascular and Metabolic Diseases Schering-Plough Research Institute Kenilworth, New Jersey

DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEMBER (Voting)

Timothy S. Lesar, Pharm.D. Director of Pharmacy Albany Medical Center Albany, New York

Scribes, LLC Toll Free 1-800-675-8846 www.scribesllc.com

5

Document info
Document views466
Page views466
Page last viewedTue Dec 06 17:22:16 UTC 2016
Pages170
Paragraphs7975
Words54271

Comments